Stock info AC Immune SA | Filter  Basic-Info

Stock: AC Immune SA (US broad)

Last Price 2.92 Max Price 4.62
Min Price 2.40 1 Year return 43.14
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USA

Sector Review AC Immune SA

Loading...
Year Turnover Total sector Market share
2019 111 141,925 0.08 %
2020 15 170,231 0.01 %
2021 0 252,886 0.00 %
2022 4 238,496 0.00 %
2023 0 0 0.00 %

Advice AC Immune SA

No Records Found



News AC Immune SA

No Records Found

Annual reports AC Immune SA

No Records Found

Profile AC Immune SA

No Records Found

Results AC Immune SA

Results
2015
2016
2017
2018
2019
2020
Revenue
39
23
20
7
111
15
Costs
19
30
47
58
66
77
Profit
20
-7
-26
-51
45
-62
Margin of profit
51.85
-30.59
-130.36
-708.62
40.93
-401.30
ROI
28.53
-4.99
-22.60
-28.68
16.68
-28.74

Balance AC Immune SA

Balance
2015
2016
2017
2018
2019
2020
Equity
71
142
117
178
272
215
Debt
9
14
15
19
27
23
Total assets
80
156
132
197
299
239
Solvency
88.88
91.21
88.51
90.36
91.04
90.26
Cash
77
152
124
186
289
226
Cashflow
44
-6
-22
-44
55
-60
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
4.96
-0.41
-1.46
-2.33
2.06
-2.56

Details AC Immune SA

Details
2016
2017
2018
2019
2020
Price
0.0
12.98
12.80
9.45
8.52
Eps
-0.14
-0.46
-0.82
0.64
-0.86
Price/earnings-ratio
0.0
-28.22
-15.61
14.77
-3.40
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
2.51
2.04
2.63
3.79
3.00
Market to book
0.0
0.16
0.21
0.40
1.03
Cashflow per stock
-0.10
-0.39
-0.65
0.77
-0.83
Stocks
57
57
68
72
72
Market Cap
0.00
744.47
864.80
679.07
210.06

Dividend AC Immune SA

Price info AC Immune SA

Date
Price
17 Dec 2024
2.92
10 Dec 2024
3.14
06 Dec 2024
3.18
03 Dec 2024
3.21
29 Nov 2024
3.36
27 Nov 2024
3.40
13 Nov 2024
3.06
08 Nov 2024
3.27
05 Nov 2024
2.94
31 Oct 2024
2.97
29 Oct 2024
3.00
23 Oct 2024
3.11
19 Oct 2024
3.13
16 Oct 2024
3.20
14 Oct 2024
3.32
05 Oct 2024
3.38
02 Oct 2024
3.75
27 Sep 2024
3.70
20 Sep 2024
3.69
17 Sep 2024
3.27
13 Sep 2024
3.05
28 Aug 2024
3.06
26 Aug 2024
3.08
23 Aug 2024
3.06
11 Aug 2024
3.28
07 Aug 2024
3.34
05 Aug 2024
3.62
01 Aug 2024
4.09
30 Jul 2024
4.05
26 Jul 2024
3.91
Overig aandelennieuws
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
AC Immune Announces Pricing of Underwritten Offering of Common Shares
AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
Logoanalist
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2024 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo